bio rad chemidoc universal western blot imager (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
99
Structured Review
Bio-Rad
bio rad chemidoc universal western blot imager
Bio Rad Chemidoc Universal Western Blot Imager, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 34964 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bio+rad+chemidoc+universal+western+blot+imager/ChemiDoc+Imaging+System/pm41077347-161-5-5
Average 99 stars, based on 34964 article reviews
Bio Rad Chemidoc Universal Western Blot Imager, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 34964 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bio+rad+chemidoc+universal+western+blot+imager/ChemiDoc+Imaging+System/pm41077347-161-5-5
Average 99 stars, based on 34964 article reviews
bio rad chemidoc universal western blot imager - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Imaging:Article Title: Prophylactic Treatment with Amnion Progenitor Cell Secretome Mitigates Traumatic Optic Neuropathy. Article Snippet: Traumatic optic neuropathy (TON), often resulting from repetitive mild traumatic brain injury (r-mTBI), is a major contributor to irreversible visual impairment, with few preventive therapeutic options available.. This study evaluates the prophylactic efficacy of ST266, a biologically active secretome derived from amnion epithelial cells, in mitigating TON-related visual and cognitive dysfunction in a murine model of r-mTBI.. Mice received five closed-head injuries spaced 48 hours apart, preceded by intranasal delivery of ST266 starting 24 hours before the first injury and administered twice daily for ten days. Western Blot:Article Title: Prophylactic Treatment with Amnion Progenitor Cell Secretome Mitigates Traumatic Optic Neuropathy. Article Snippet: Traumatic optic neuropathy (TON), often resulting from repetitive mild traumatic brain injury (r-mTBI), is a major contributor to irreversible visual impairment, with few preventive therapeutic options available.. This study evaluates the prophylactic efficacy of ST266, a biologically active secretome derived from amnion epithelial cells, in mitigating TON-related visual and cognitive dysfunction in a murine model of r-mTBI.. Mice received five closed-head injuries spaced 48 hours apart, preceded by intranasal delivery of ST266 starting 24 hours before the first injury and administered twice daily for ten days. |